Skip to content
‹ Back to IndustriesHealthcare

CurveBeam AI Cast – Reimaging Patient-Specific Deformity Correction Planning

The foot and ankle are complex structures comprised of 26 small bones and 29 muscles. With so many structures and an incredible amount of variation in how deformities can present, surgical corrections aren’t so simple. For example, there are more than 100 operations that can be performed for hallux valgus deformities, commonly known as bunions….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from CurveBeam AI on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The foot and ankle are complex structures comprised of 26 small bones and 29 muscles. With so many structures and an incredible amount of variation in how deformities can present, surgical corrections aren’t so simple. For example, there are more than 100 operations that can be performed for hallux valgus deformities, commonly known as bunions. 3D planning helps to address the variations and nuances of foot and ankle surgeries to assist in obtaining optical post-surgical outcomes.

How is one company, RedPoint Medical 3D, making 3D planning more accessible to orthopedic surgeons?

On this episode of CurveBeam AI, host Lew Schon, MD, Director of Orthopedic Innovation at the Institute of Foot and Ankle Reconstruction at Mercy Medical Center, speaks with Dr. Adam Perler, DPM, Co-Founder & Chief Innovations Officer at RedPoint Medical 3D and Surgeon at Alexander Orthopaedic Associates, to discuss the RedPoint Medical 3D has created a vendor-agnostic, streamlined process for 3D modeling, custom surgical planning, and 3D printed cut guides.

Dr. Schon and Dr. Perler also discussed…

  1. The role that 3D printing plays in helping surgeons visualize their surgical approaches
  2. How older and more experienced surgeons have reacted to the redpointing philosophy
  3. What the process of redpointing looks like from receiving a 3D CT scan to the point of the surgical procedure

Dr. Perler explained how RedPoint Medical 3D was named. “Redpointing is where a professional climber will write down all the details of the route, where they’re going to place their hands, where they’re going to place their feet. And then they hand that plan to a judge and they don’t actually touch the rock face until they hand the plan over. Then they go about their climb. If they do it perfectly, that’s called redpointing. So, to me, this was a vision of what I wanted to be able to help surgeons do with their surgeries and I would love to get to the point where redpointing becomes a very grammatical term for us all to describe, ‘Hey, I’ve got this big surgery coming up’ and another surgeon says, ‘Hey, are you going to redpoint that?’ meaning are you going to meticulously plan that and flawlessly execute that?”

Dr. Adam Perler, Doctor of Podiatric Medicine (DPM), is an experienced foot and ankle surgeon passionate about new product development for surgeries. He is Co-Founder & Chief Innovations Officer at RedPoint Medical 3D and Surgeon at Alexander Orthopedic Associates. Dr. Perler earned his B.A. in Biology from Indiana University Bloomington and his DPM from Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine. He is residency-trained at Palmetto General Hospital’s Surgical Residency and later pursued fellowship training from the Ilizarov Orthopedic Lower Extremity Reconstructive Fellowship and the AO Trauma Fellowship in Hannover, Germany.

CurveBeam AI

Part of this channel

CurveBeam AI

AI-powered 3D bone analysis for orthopedic surgical planning.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

Humana's $2.8B BlackRock deal lets it buy back CenterWell clinics starting in 2028

BlackRock's $2.8 billion buys majority ownership of a joint venture holding about 150 CenterWell clinics, replacing WCAS as Humana's outside investor. CenterWell keeps a minority stake and keeps running the clinics. The terms set a timeline: two years of expected growth spending, an option for Humana to buy clinics back from 2028, and a BlackRock right to start a sale of any clinics still in the venture at the end of 2033, with CenterWell getting the first offer. The deal is expected to close in the fourth quarter, subject to regulatory approvals.

  • 01BlackRock's $2.8 billion buys majority ownership of about 150 CenterWell clinics, while Humana keeps day-to-day management and an option to repurchase clinics starting in 2028.
  • 02The 2028 buyback and 2033 sale terms apply to the roughly 150 clinics in the new joint venture. CenterWell Senior Primary Care runs 250 clinics in total.
  • 03The deal’s lower-cost-of-capital claim will be tested after closing—first by how the venture deploys new capital over the next two years to support clinics, open locations and pursue acquisitions, and then by Humana’s 2028 decision on whether to start buying clinics back.

Nov 12, 2026

Healthcare AI should give doctors attention back, not shorter visits

Healthcare AI should give doctors attention back, not shorter visits

Healthcare organizations should deploy AI to give clinicians back attention and capacity for better decisions, not simply shorten visits. Landry argues AI should fit into existing workflows with insights appearing at the right time, and that organizations should set clear governance and automation boundaries before deployment and measure what changes for patients, clinicians and the organization.

  • 01AI success in healthcare should expand clinician capacity for thoughtful care, not optimize for visit speed; a three-minute appointment is not patient-centered innovation.
  • 02Design AI into workflows clinicians already use with insights appearing at the right moment, making adoption a workflow problem rather than a training problem.
  • 03Set automation boundaries before deploying AI, specifying what it may do alone, what it recommends for clinician decision-making, and what requires explicit human control and accountability.

Nov 11, 2026

Black Book: AI may make some outsourced health plan work cheaper to bring in-house

Black Book: AI may make some outsourced health plan work cheaper to bring in-house

U.S. health plan administrative costs rose 2.7% to about $69.2 billion in the first half of 2026, even as margins improved to 4.1%. Black Book Research's 2027 outlook says AI is starting to move payer sourcing in both directions. Demand for specialist vendors stays strong in some functions, while automation could make in-house or hybrid models viable in others. The report recommends comparing each major outsourced service with rival vendors and the best internal or hybrid option, and checking whether projected savings become actual cash.

  • 01Every major outsourced payer service should be benchmarked against a rival vendor and against the plan's best feasible internal or hybrid model, a three-way contest at each renewal.
  • 02Staffing reductions, payment recoveries, avoided vacancies and productivity improvements may not translate into recurring cash, so plans shouldn’t assume outsourcing savings can fund AI until the service, AI and funding cases are evaluated separately.
  • 03Provider data sits on both sides of the sourcing question: it is a top pain point and a specialist-demand area, yet also one of the functions where automation could make hybrid or in-house models viable.

Nov 11, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512